Cargando…
Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine
Neuroblastoma cells highly express the disialoganglioside GD2, a tumor-associated carbohydrate antigen, which is also expressed in neurons, skin melanocytes, and peripheral nerve fibers. Immunotherapy with monoclonal anti-GD2 antibodies has a proven efficacy in clinical trials and is included in the...
Autores principales: | Galassi, Lucrezia, Rossi, Martina, Lodeserto, Pietro, Lenzi, Monia, Borsetti, Francesca, Voltattorni, Manuela, Farruggia, Giovanna, Blasi, Paolo, Orienti, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966923/ https://www.ncbi.nlm.nih.gov/pubmed/36839972 http://dx.doi.org/10.3390/pharmaceutics15020648 |
Ejemplares similares
-
Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines
por: Lodeserto, Pietro, et al.
Publicado: (2022) -
Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule
por: Potenza, Rosa Luisa, et al.
Publicado: (2022) -
Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
por: Orienti, Isabella, et al.
Publicado: (2020) -
Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19
por: Orienti, Isabella, et al.
Publicado: (2020) -
A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model
por: Orienti, Isabella, et al.
Publicado: (2019)